In timely and incisive analysis, our experts parse the latest development issues and events, providing practical solutions to new and emerging challenges.
International institutions, development agencies, and the global development community must step up to assist the growing financial and humanitarian crisis. CGD experts advise.
We’ve updated our 2022 working paper with Laura Moscoviz on long run trends in education quality with several new surveys from around the world. Notably, a new survey round for India (NFHS-5) casts doubt on earlier data (NFHS-3). Dropping the suspect data, India’s current learning levels are unchang...
In a new paper, we examine the connection between exposure to lead—a dangerous but prevalent neurotoxicant—and children’s learning outcomes. We find that lead poisoning alone could account for more than 20 percent of the learning gap between rich and poor countries. Given the comparative ease of, sa...
It’s rare to read an education report that doesn’t mention the learning crisis. As data on low learning levels have emerged in recent years, global education aid has swung its focus sharply toward improving test scores among primary school children. Of course, learning to read is a good thing in its...
The global debate around high-stakes exams is strongly influenced by research from high-income countries. That research emphasises who gets sorted into the “best” schools. An alternative perspective that hasn’t received enough attention takes exams as artificial bottlenecks that prevent many childre...
UNESCO tells us that only one in seven low- and middle-income countries knows how much learning has been lost due to COVID school closures. Where there has been no measurement, simulations of learning loss are beginning to take the place of empirical facts. Yet countries examine millions of kids eac...
This is the third of our biennial updates on global education aid finance. In these posts we examine aid data from the OECD, analysing how much aid is going to education, where it is allocated, by who, and through what channels. The latest available data, which we use for this analysis, is from 2021...
In the 2000s, cost-effectiveness analysis said it was a bad use of money to send antiretroviral drugs to low-income countries—drugs that ended up saving millions of lives.